These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33298176)

  • 1. Exploring the role of RALYL in Alzheimer's disease reserve by network-based approaches.
    Zhang Y; Wang J; Liu X; Liu H
    Alzheimers Res Ther; 2020 Dec; 12(1):165. PubMed ID: 33298176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging.
    Lee DH; Lee P; Seo SW; Roh JH; Oh M; Oh JS; Oh SJ; Kim JS; Jeong Y
    Neuroimage; 2019 Feb; 186():690-702. PubMed ID: 30503934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.
    Wang M; Roussos P; McKenzie A; Zhou X; Kajiwara Y; Brennand KJ; De Luca GC; Crary JF; Casaccia P; Buxbaum JD; Ehrlich M; Gandy S; Goate A; Katsel P; Schadt E; Haroutunian V; Zhang B
    Genome Med; 2016 Nov; 8(1):104. PubMed ID: 27799057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RALY RNA binding protein-like reduced expression is associated with poor prognosis in clear cell renal cell carcinoma.
    Cui ZW; Xia Y; Ye YW; Jiang ZM; Wang YD; Wu JT; Sun L; Zhao J; Fa PP; Sun XJ; Gui YT; Cai ZM
    Asian Pac J Cancer Prev; 2012; 13(7):3403-8. PubMed ID: 22994768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network-Based Substrate of Cognitive Reserve in Alzheimer's Disease.
    Serra L; Mancini M; Cercignani M; Di Domenico C; Spanò B; Giulietti G; Koch G; Marra C; Bozzali M
    J Alzheimers Dis; 2017; 55(1):421-430. PubMed ID: 27662319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2.
    Wang X; Wang J; Tsui YM; Shi C; Wang Y; Zhang X; Yan Q; Chen M; Jiang C; Yuan YF; Wong CM; Liu M; Feng ZY; Chen H; Ng IOL; Jiang L; Guan XY
    Nat Commun; 2021 Mar; 12(1):1518. PubMed ID: 33750796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of potential hub genes of Alzheimer's disease by weighted gene co-expression network analysis].
    Xue J; Liu J; Geng M; Yue J; He H; Fan J
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1752-1762. PubMed ID: 35012905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer's disease.
    De Jager CH; White CC; Bennett DA; Ma Y
    Transl Psychiatry; 2021 Feb; 11(1):139. PubMed ID: 33627625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex specific molecular networks and key drivers of Alzheimer's disease.
    Guo L; Cao J; Hou J; Li Y; Huang M; Zhu L; Zhang L; Lee Y; Duarte ML; Zhou X; Wang M; Liu CC; Martens Y; Chao M; Goate A; Bu G; Haroutunian V; Cai D; Zhang B
    Mol Neurodegener; 2023 Jun; 18(1):39. PubMed ID: 37340466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
    Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
    Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
    Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
    Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer's disease.
    Franzmeier N; Düzel E; Jessen F; Buerger K; Levin J; Duering M; Dichgans M; Haass C; Suárez-Calvet M; Fagan AM; Paumier K; Benzinger T; Masters CL; Morris JC; Perneczky R; Janowitz D; Catak C; Wolfsgruber S; Wagner M; Teipel S; Kilimann I; Ramirez A; Rossor M; Jucker M; Chhatwal J; Spottke A; Boecker H; Brosseron F; Falkai P; Fliessbach K; Heneka MT; Laske C; Nestor P; Peters O; Fuentes M; Menne F; Priller J; Spruth EJ; Franke C; Schneider A; Kofler B; Westerteicher C; Speck O; Wiltfang J; Bartels C; Araque Caballero MÁ; Metzger C; Bittner D; Weiner M; Lee JH; Salloway S; Danek A; Goate A; Schofield PR; Bateman RJ; Ewers M
    Brain; 2018 Apr; 141(4):1186-1200. PubMed ID: 29462334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic-overlapping co-expression module detection with application to Alzheimer's Disease.
    Manners HN; Roy S; Kalita JK
    Comput Biol Chem; 2018 Dec; 77():373-389. PubMed ID: 30466046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Causal Modeling of the Dynamic Biomarker Cascade in Alzheimer's Disease.
    Petrella JR; Hao W; Rao A; Doraiswamy PM
    Comput Math Methods Med; 2019; 2019():6216530. PubMed ID: 30863455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.
    Perneczky R; Kempermann G; Korczyn AD; Matthews FE; Ikram MA; Scarmeas N; Chetelat G; Stern Y; Ewers M
    BMC Med; 2019 Feb; 17(1):47. PubMed ID: 30808345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease.
    Beyer L; Schnabel J; Kazmierczak P; Ewers M; Schönecker S; Prix C; Meyer-Wilmes J; Unterrainer M; Catak C; Pogarell O; Perneczky R; Albert NL; Bartenstein P; Danek A; Buerger K; Levin J; Rominger A; Brendel M
    Neuroimage Clin; 2019; 24():101949. PubMed ID: 31398553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying the molecular systems that influence cognitive resilience to Alzheimer's disease in genetically diverse mice.
    Heuer SE; Neuner SM; Hadad N; O'Connell KMS; Williams RW; Philip VM; Gaiteri C; Kaczorowski CC
    Learn Mem; 2020 Sep; 27(9):355-371. PubMed ID: 32817302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients.
    Qian XH; Liu XL; Chen SD; Tang HD
    Front Immunol; 2022; 13():986346. PubMed ID: 36159817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis to identify transcriptome-wide dysregulation of Alzheimer's disease in genes and isoforms.
    Fan C; Chen K; Zhou J; Wong PP; He D; Huang Y; Wang X; Ling T; Yang Y; Zhao H
    Hum Genet; 2021 Apr; 140(4):609-623. PubMed ID: 33140241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.